Faegre, Latham Drive $1.1B Boston Scientific-Preventice Deal

Faegre Drinker-counseled Boston Scientific will pay as much as $1.125 billion to scoop up Latham & Watkins-advised Preventice Solutions, a private equity-backed medical device maker focused on issues related to the heart,...

Already a subscriber? Click here to view full article